V1a Vasopressin R/AVPR1A Antibody (612130) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10932Z
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 612130
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human V1a Vasopressin R/AVPR1A
Accession # P37288
Accession # P37288
Specificity
Detects human V1a Vasopressin R/AVPR1A in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for V1a Vasopressin R/AVPR1A Antibody (612130) [DyLight 755]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: V1a Vasopressin R/AVPR1A
Long Name
Arginine Vasopressin Receptor 1A
Alternate Names
AVPR V1a, AVPR1A, V1a VasopressinR, V1aR
Additional V1a Vasopressin R/AVPR1A Products
Product Documents for V1a Vasopressin R/AVPR1A Antibody (612130) [DyLight 755]
Product Specific Notices for V1a Vasopressin R/AVPR1A Antibody (612130) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...